血必净与低分子肝素对严重脓毒症患者凝血功能及预后的影响

目的 比较血必净与低分子肝素(low molecular weight heparin,LMWH)对严重脓毒症患者凝血功能及疾病预后的影响,以指导脓毒症的治疗.方法 将89例经随访取得有效数据的严重脓毒症患者随机(随机数字法)分为3组,血必净组(A组)、LMWH组(B组)和常规组(C组).C组给予常规治疗,A组及B组在常规治疗的基础上分别加用血必净注射液和LMWH联合治疗.3组分别于治疗前及治疗后7 d检测凝血指标,记录APACHE Ⅱ评分,随访统计住院天数及28 d病死率.统计分析采用成组t检验、方差分析、q检验、x2检验和秩和检验,以P＜0.05为差异具有统计学意义.结果 ①治疗后与治疗前组内比较,A组各凝血指标均有明显改善(P＜0.01),其余2组有部分凝血指标改善(P＜0.05或P＜0.01);治疗后经组间比较,A组各凝血指标较其他2组改善明显(P＜0.05),B组与C组比较,只有部分指标改善(P＜0.05).②治疗后与治疗前比较,A组及B组APACHEⅡ评分明显下降(P＜0.05);治疗后经组间比较,A组与B组APACHEⅡ评分差异无统计学意义(P＞0.05),二者分别与C组比较明显下降(P＜0.05).③3组住院天数比较差异无统计学意义(P＞0.05).④3组28 d病死率比较,A组及B组较C组28 d病死率降低,差异具有统计学意义(均P＜0.05).结论 血必净可明显改善严重脓毒症患者的凝血功能,低分子肝素只能改善部分凝血指标;二者均可降低病死率、改善预后.

Abstract：

Objective To compare between the impact of Xuebijing injectio (a Chinese herbal medicine preparation) and that of low molecular weight heparin (LMWH) on coagulation function and prognosis in patients with severe sepsis, so as to guide the treatment of sepsis. Method A total of 89 patients with severe sepsis were randomly(random number) divided into 3 groups, namely Xuebijing group (group A),LMWH group (group B) and routine group (group C). The patients of group C received a series of remedies according to the guideline for severe sepsis. The patients of group A were treated with Xuebijing injectio in addition to routine treatment. The patients of group B were treated with LMWH along with routine treatment.Data of blood coagulation function tests and APACHE Ⅱ score of patients in three groups before and after treatment were analyzed respectively. The 28-day mortality and length of hospital stay were compared among three groups. All data were analyzed by using t-test, Analysis of Variance, q-test, x2-test and rank sum treatment, all markers of the blood coagulation function tests in group A improved significantly after treatment (P＜0.01), while only some markers of the blood coagulation function tests improved in the other two groups ( P ＜ 0. 05 or P ＜ 0. 01 ); After treatment, the blood coagulation function in group A improved significantly more than that in other two groups ( P ＜ 0.05 ), while there were some markers of the blood coagulawith the data before treatment, the APACHE Ⅱ score in group A and group B decreased after treatment (P＜0.05). After treatment, the APACHE Ⅱ score of group A and group B decreased significantly more than that of group C ( P ＜ 0.05). But there was no significant difference between group A and group B ( P ＞Xuebijing obviously improves the blood coagulation function in patients with severe sepsis, while LMWH only improves some markers of the coagulation function tests. Both Xuebijing and LMWH reduce mortality and improve prognosis of patients with sepsis.     

神经生长因子早期治疗中重度新生儿缺氧缺血性脑病的疗效

Objective To observe the curative efects of never growth factor (NGF)on neonates with moderate and severe hypoxic-ischemic encephalopathy (HIE). Methods Eighty-six neonates with HIE were randomly divided into NGF treatment group and control group. The control group (42 cases)were received routine treatment (including cerebrolysin and citicoline) ;the treatment group (44 cages)were given NGF on the basis of routine treatment as early as possible (within 6 hours after birth). Brain CT, neonatal behavioral neuro-logical assessment(NBNA) and children' s development center of China(CDCC) at 3 and 6 months after birth were proformed in both groups. Results Brain CT, NBNA and CDCC markers in treatment group were better than those in control group (P＜ 0. 05). There were great diferences between two groups (P＜ 0. 01). Conclusion Using NGF on the basis of the routine treatment as early as possible after resuscitation can reduce markely the severity of asphyxia induced brain damage in neonates. It is very effective using NGF in treating HIE in neonates.     

肠内营养对重型破伤风患者营养支持的探讨

Objective To study the effect of enteral nutrition on patients with severe tetanus. Methods The patients totaled 60 cases were divided into two groups with 30 cases in each. The patients in EN group were treated with enteral nutrition on basis of routine treatment, control group was treated with total parenteral nutrition (TPN). The indicators values of BMI, TSF, MAMC, TP, PAm, m, ALB and Hb were tested on the day before nutrition supports and after nutrition supports 10 days later in two groups. Adverse reaction and the treatment effect were observed simultaneously. Results With nutritional supports 10 days later, two groups had no obvious decline in BMI, TSF and MAMC. TP, PA, ALB and Hb of EN group were higher than those of control group (P＜0.05) . Complication rate of EN group was lower than that of control group, there was significant differences (P＜0.05) . Conclusions Early EN may improve protein metabo lism in patients with severe tetanus and nutritional status.     

肠内营养对重型破伤风患者营养支持的探讨

Objective To study the effect of enteral nutrition on patients with severe tetanus. Methods The patients totaled 60 cases were divided into two groups with 30 cases in each. The patients in EN group were treated with enteral nutrition on basis of routine treatment, control group was treated with total parenteral nutrition (TPN). The indicators values of BMI, TSF, MAMC, TP, PAm, m, ALB and Hb were tested on the day before nutrition supports and after nutrition supports 10 days later in two groups. Adverse reaction and the treatment effect were observed simultaneously. Results With nutritional supports 10 days later, two groups had no obvious decline in BMI, TSF and MAMC. TP, PA, ALB and Hb of EN group were higher than those of control group (P＜0.05) . Complication rate of EN group was lower than that of control group, there was significant differences (P＜0.05) . Conclusions Early EN may improve protein metabo lism in patients with severe tetanus and nutritional status.     

脓毒症患者血清可溶性髓系细胞表达的触发受体-1水平及与预后的关系

Objective To approach the relationship between the contents of soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) and prognosis in patients with sepsis. Methods Using prospective, control study design, a total of 50 patients with sepsis who were admitted in intensive care unit (ICU) of the Second Hospital of Tianjin Medical University from March to December in the year of 2009 were enrolled. Firstly, the patients were divided into sepsis (n=28) and severe sepsis (n=22) groups according to the patients' condition. Then the patients were divided into survival group (n = 34) and death group (n = 16)according to the clinical outcome at 28 days after onset of sepsis. Clinical and laboratory data including blood routine tests, blood chemistry, blood gas analysis, C-reactive protein (CRP) and procalcitonin (PCT) were collected on the 1st, 3rd and 7th day after onset. Acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ ) score was determined. sTREM-1 levels were determined using enzyme linked immunosorbent assay (ELISA) method. Correlation analysis of the sTREM-1, APACHE I score, white blood cell count (WBC) and CRP, using Logistic regression analysis. A total of 30 healthy persons were enrolled into the control group. Results The sTREM-1 levels (ng/L) in 50 septic patients on the 1st day were higher than those of the healthy persons (52. 80±9. 30 vs. 23. 29±6. 22, P＜0. 01). The sTREM-1 levels (ng/L) in severe sepsis group on the 1st, 3rd and 7th day (58. 25±10. 59, 65. 75±13. 57, 50.18±21. 73) were higher than those of the sepsis group (48.55±5.20, 42.85±8.54, 34.02±12.86, P＜0.05 or P＜0.01). The sTREM-1 levels (ng/L) of the survival group on the 1st, 3rd and 7th day (53. 07± 10. 47, 45. 04±9. 89,32. 84 ±8. 42) were decreased with the progression of the ailment. The sTREM-1 levels did not differ significantly between the control group and survival group on the 7th day (P＞0. 05). The sTREM-1 levels (ng/L) in the death group on the 1st, 3rd and 7th day were increased with the progression of the ailment (52.27±6.42, 69.67±12.83, 75. 70± 10. 55), and the level was significantly higher than that in survival group on the 3rd and 7th day (both P＜0. 01). The contents of sTREM-1 were positive correlated with APACHE Ⅱ score (r= 0.657, P＜0. 01), but not correlated with WBC (r= 0.023, P＞0. 05), whilesomewhat correlated with CRP (r=0. 150, P＜0.10). Logistic regression analysis showed that sTREM-1 [odds ratio (OR) = 0. 893,P = 0. 000] and APACHE I score (OR = 0.771, P = 0.000) might be potential prognostic factors for septic patients. The area under the receiver operator characteristic curve was 0. 868 and 0.930. The sensitivity of prognostic evaluation was 81.1% and specificity was 74.5% with sTREM-1 50 ng/L, and the sensitivity was 83. 8% and specificity was 86. 3% with APACHE Ⅱ score 20 to estimate the outcome. Conclusion The serum sTREM-1 are elevated at early stage in sepsis patients. It can reflect the severity of the condition. The sTREM-1 level, which might be considered as a potential prognostic factor for septic patients, is significantly correlated with APACHE Ⅱ score.     

血液灌流在急性重度有机磷农药中毒治疗中的应用

Objective The purpose of the study was to evaluate the applications and value of hemoperfusion (HP) in the treatment of acute severe organophosphorus pesticide poisoning. Method Patients who had been di-agnosed with acute severe organophosphorus pesticide poisoning were selected for the study between January and October 2008. The patients were randomly divided into three groups: A group (HA230-type hemoperfutor), B group (HA330-type hemoperfutor), and C group (control group, without HP treatment). Patients in the three groups underwent the same conventional treatments except for the HP. The curative effect, cholinesterase (CHE) activities and the levels of TNF-α, IL-1β,IL-6, and IL-8 in serum were statisticaUy analyzed. Results The cure rate of the A and B groups was significantly higher than the C group (P≤0.05). The cumulative dosage of at-ropine and average hospitalization days in the C group were significantly higher than the patients in the A and B groups (P <0.01). As well, the CHE activities were obviously up-regulated after the HP h-eatment in A and B groups (P < 0.01). At 24 hours after HP treatment, the level of CHE activities in the B group was much higher than the level in the A group (P≤0.05). Levels of TNF-α, IL-1β, IL-6, and IL-8 were down-regulated after the HP treatment in the A and B groups (P < 0.01). An internal comparison revealed that the levels of TNF-α, IL-1β, IL-6 and IL-8 were lower in the B group than the A group (P <0.01). Conclusions HP can be used for treating acute severe organophosphorus pesticide poisoning, likely functioning by absorbing poisons from the blood and acting to reduco inflammatory cytokines.     

Prognostic value of CD4~+CD25~+ Tregs as a valuable biomarker for patients with sepsis in ICU

BACKGROUND: Sepsis is a common complication ofinfections, burns, traumas, surgeries, poisonings, and post-cardiopulmonary resuscitation. The present study aimed to investigate prognostic value of CD4+CD25+ regulatory T cells(Treg) in peripheral blood of patients with sepsis.METHODS: Periphery blood from 28 patients diagnosed with sepsis was collected on day 1 and 7 after hospitalization in the ICU of Shanghai Changzheng Hospital between December 2013 to April 2014. The blood was used for analyses of Treg ratio using flow cytometry and for analyses of blood routine test, C-reactive protein(CRP), bilirubin, procalcitonin(PCT), and coagulation. APACHE II and sequential organ failure assessment(SOFA) scores were also investigated. The results were compared between two outcome groups of survival or death to evaluate prognostic value for sepsis.RESULTS: The patients had an average age of 60.36±15.03 years, APACHE II score 16.68±7.00, and SOFA score 7.18±3.78. Among the 28 patients, 12 had severe trauma(42.9%), 10 had septic shock(35.7%), and 9(32.2%) died. The median ratio of Tregs was 2.10%(0.80%, 3.10%) in the survival group vs. 1.80%(1.15%, 3.65%) in the death group(Z=–0.148, P=0.883) on day 1; however it was signifi cantly changed to 0.90%(0.30%, 2.80%) vs. 5.70%(2.60%, 8.30%)(Z=–2.905, P=0.004).CONCLUSION: With better prospects for clinical application, dynamic monitoring of Tregs ratio in peripheral blood has potential value in predicting prognosis of sepsis.     

穴位注射治疗脑卒中假性球麻痹30例疗效观察

Objective To observe the curative effect of injectio ad acumen to 30 supranuclear paralysis cases with dysphagia. Methods cases were randomly divided into injectio ad acumen and single acupuncture treatment group, each of them has 30 cases respectively. Improvement of dysphagia was the main obserable index, and the data of pre-and post-treatment was being statistical treatment. Results the effective rate of injectio ad acumen and single acupuncture treatment group was 93.33% and 70.00% respetively, so there has significant stastical difference between the two groups(P ＜0. 01). Conclusion injectio ad acumen treatment has significant effect in patients with dysphagia.     

黄芪注射液对严重脓毒症患者的疗效观察

Objective To observe the effects of Radix Astragali injection on severe septic patients. Method This was a prospective study. Fifty severe septic patients admitted in ICU from 2006 to 2008 were col-lected, malignent disease like carcinoma, pregnant ones were excluded. They were randomly divided into two groups: Radix Astragali injection treatment group (n = 30) and control one (n = 20). The data of the two groups were comparable. With the same basic therapy, the experimental group treated with additional Radix Astragali in-jection. Then, APACHE Ⅱ scores were calculated on day 0(before therapy), day 7 and day 14 after treatment with Radix Astragali injection, and the 28th day mortality was also calculated for both groups. Blood CD4, CD8, CD4/CD8, NK-cell expression level was measured by direct immunofluorescence, IL-1β, IL-6, TNF-α level was tested by ELASA. SPSS 11.5 software, was used for statistic. Results The APACHE Ⅱ scores in Radix Astragali treatment group were 20.73±5.06, while in control groups were 35.00±3.70 after treatment for 14 days, and mortality in the 28th day was 25.3% and 41.6% respectively, there were significant deferences between the two groups (P < 0.05). At 14 days after treatment, the level of CD4, CD4/CD8 and NK-cell in the Radix Astragali treatment group was significantly increased, with (34.11±14.09) %, (2.05±0.98) %, (28.83±8.08) %, re-spectively, and compared with control group, there were significant differences (P < 0.01). Though, the level of CD8, IL-6 and TNF-α was showed (20.84±9.84) %,(710.87±313.52) pg/mL,(14.63±30.38) pg/mL respectively, significantly decreased after treatment with Radix Astragali injection, there were also significant dif-ferences between the two groups (P < 0.01). Conclusions Radix Astragali injection can improve the immunity disorder of severe septic patients, it will be a hopeful therapy for severe sepsis.     

雾化吸入灭活草分枝杆菌治疗中度支气管哮喘的临床研究

Objective To introduce inhaled inactivated-mycobacterium phlei on prevention and treatment of moderate bronchial asthma to observe the clinical effect. Method This study was a prospective and controlled study. The patients diagnosed with asthma in our out-patient from March 2009 to December 2010 were collected, who met the following conditions were included in the study: age≥ 14 years; met the criteria of moderate chronic persistent bronchial asthma in Global Initiative for Asthma (GINA) in 2008; suspended receiving systemic corticosteroids, Montelukast, ketotifen and other anti-inflammatory and anti-allergic drugs in one month; no significant respiratory tract infections; and other serious illnesses or abnormalities known.A total of 100 patients with asthma were selected, including 37 males and 63 females, age (32.11 ± 12.95 )years. The patients were randomly(random number) divided into two groups: A group(treatment group; 16males and 34 females, age 33.56 ± 14.23 years) and B group (control group; 21 males and 29 females,age 30.66 ± 11.50 years); 50 in each group. No significant difference was noted between the two groups on age and gender composition. The patients in A group were treated with inhaled inactivated-mycobacterium phlei F. U. 36 Injection 1.72 μg/mL × 2 that adding 3 mL normal saline, once a day for 5 days. The patients in B group were treated with salmeterol xinafoate and fluticasone propionate powder for inhalation (50/100 μg), twice daily for sustainable use. The patients in the two groups were observed for one month. During this course, the patients in the two groups could inhale the salbutamol sulphate aerosol as need to relieve symptoms. And the number of using was recorded. Pulmonary function test and asthma provocative test were carried out on the Day O, 6 and 31. ACT scores were measured before and after the treatment. Results On Day 6 and 31 after treatment, the negative conversion rates of asthma provocative test of the patients in A group were 82% and 78% respectively, B group were 84% and 90% respectively. Provocative test of the patients in the two groups were negative conversion significantly before and after treatment. There was no significant difference between the two groups by chi-square test (P ＞ 0. 05 ). Completely random designed data was analyzed by analysis of variance. The analysis showed that the accumulated doses of methacholine of the patients in the two group increased significantly ( P ＜ 0. 05 ), but no difference between the two groups.There was a improvement trend on forced expiratory volume in one second( FEV1 )of the patients in A group after treatment, but no difference. FEV1 of the patients in B group increased significantly higher ( P ＜0.05), which was significantly higher than A group on the 31th day (P ＜0. 05); Peak expiratory flow (PEF) of the patients in the two group increased significantly on Day 6 and 31 after treatment (P ＜0.05 ).On Day 31, B group was significantly higher than A group ( P ＜ 0. 05 ); Scores of asthma control test (ACT)of the patients in the two group were significantly increased, and the number of using of salbutamol sulfate aerosol was significantly reduced (P ＜0.01 ). B group was obvious than group A (P ＜0.05 ). During treatment, there were only two adverse reaction cases of transient low fever; most obvious was on the third day.Conclusions Inhaled inactivated-mycobacterium phlei would inhibit the airway hyperresponsiveness of the patients with moderate bronchial asthma in short time, improve the symptoms, reduce the acute exacerbation, and reduce the use of rescue medication, which has the roles of prevention and treatment of moderate asthma in a certain period of time.     

Tiotidine and cimetidine--kinetics and dynamics

Tiotidine and cimetidine kinetics and dynamics were compared to assess mechanisms of the longer duration of effect of tiotidine in man. Both drugs has similar lag times for absorption. Tiotidine with a meal was more slowly absorbed than when fasting and was also more slowly absorbed than cimetidine with a meal. The elimination rates for both drugs did not differ; they were both approximately 2 to 3 hr. Oral doses of cimetidine achieved areas under the plasma concentration curve approximately three times that of tiotidine but these concentrations were only 1/10 as potent. The cimetidine concentration inducing 50% inhibition of food-stimulated gastric acid secretion was 0.41 +/- 0.04 whereas it was 0.04 +/- 0.003 microgram/ml for tiotidine. The effect of tiotidine lasted longer than that of cimetidine because the doses recommended for use in man resulted in higher concentrations in plasma relative to effective concentration than clinical doses of cimetidine.